Indomethacin and Cardiac Bypass Surgery

This study has been completed.
Sponsor:
Information provided by:
Queen's University
ClinicalTrials.gov Identifier:
NCT01073670
First received: February 19, 2010
Last updated: February 22, 2010
Last verified: February 2010

February 19, 2010
February 22, 2010
August 2000
April 2002   (final data collection date for primary outcome measure)
amount of blood lost via chest drains during and following cardiac bypass surgery [ Time Frame: during surgery and then until chest drains removed (< 24 hours) ] [ Designated as safety issue: Yes ]
Same as current
Complete list of historical versions of study NCT01073670 on ClinicalTrials.gov Archive Site
  • blood clotting indices (i.e., conventional and using thromboelastography) [ Time Frame: perioperative period until 24 hours post-operative ] [ Designated as safety issue: Yes ]
  • Morphine equivalents required to provide effective analgesia [ Time Frame: perioperative period until 24 hours post-operative ] [ Designated as safety issue: Yes ]
    The milligram quantities of morphine or the equivalents of morphine administered (in addition to the acetaminophen, indomethacin or combination therapy) were recorded and compared between groups. This provided an indication of how effective each of our interventions were at providing pain relief.
  • pain scores [ Time Frame: perioperative period until 24 hours post-operative ] [ Designated as safety issue: Yes ]
    Resting pain scores were recorded for all subjects at 6, 12 18 and 24 hours following surgery and compared between groups. These scores provided an indication as to the efficacy of each of our interventions at providing pain relief.
Same as current
Not Provided
Not Provided
 
Indomethacin and Cardiac Bypass Surgery
Quantification of Postoperative Coagulation Following Administration of Indomethacin to Expedite Fast-tracking of Cardiac Surgical Patients

Following signed informed consent, patients scheduled for elective cardiac surgery were randomly assigned to one of 3 groups to be given acetaminophen, Indomethacin or a combination of both immediately following induction and then at 6, 12, 18 & 24 hours following surgery. Our primary outcome measure was the amount of blood drained from the mediastinal tubes and chest drains. Secondary outcome measures included conventional blood coagulation indices as well as other measures of clotting as indicated by thromboelastography (TEG). Other secondary outcome measures included consumption of morphine equivalents and pain scores.

Not Provided
Interventional
Phase 4
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver, Investigator)
Primary Purpose: Supportive Care
Hemorrhage
  • Drug: Indomethacin
    Indomethacin was given via suppository at time of induction for anesthesia (2 x 50 mg) followed by one 50 mg suppository at 6, 12, 18 and 24 hours following cardiac bypass surgery.
    Other Name: Indocin
  • Drug: Acetaminophen & Indomethacin
    Subjects were given a loading dose of acetaminophen (1300 mg) and indomethacin (50 mg)by suppository at the time of induction for anesthesia and then given 650mg acetaminophen + 25 mg indomethacin at 6, 12, 18 and 24 hours following cardiac bypass surgery.
    Other Names:
    • Tylenol
    • Indocin
  • Drug: Acetaminophen
    Subjects were given a loading dose of 2600 mg of acetaminophen (via suppository) at time of induction for anesthesia then given 1300mg at 6, 12, 18 and 24 hours following cardiac bypass surgery.
    Other Name: Tylenol
  • Active Comparator: Acetaminophen
    Participants received a loading dose of acetaminophen (2600 mg) at induction followed by 1300 mg at 6, 12, 18 and 24 hours following cardiac bypass surgery.
    Intervention: Drug: Acetaminophen
  • Experimental: Indomethacin
    Participants were given 100 mg of indomethacin at induction and then 50 mg at 6, 12, 18 and 24 hours following cardiac bypass surgery.
    Intervention: Drug: Indomethacin
  • Experimental: Combination
    Participants were given a loading dose of 1300 mg of acetaminophen and 50 mg of Indomethacin followed by 650mg of acetaminophen and 25 mg of indomethacin at 6, 12, 18 and 24 hours following cardiac bypass surgery.
    Intervention: Drug: Acetaminophen & Indomethacin
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
82
April 2002
April 2002   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • scheduled to undergo either elective coronary artery bypass or single valve replacement
  • normal platelet count
  • normal prothrombin time
  • normal partial thromboplastin time
  • normal serum creatinine

Exclusion Criteria:

  • sensitivity to study drugs
  • history of bleeding diathesis
  • renal dysfunction
  • active peptic ulcer
Both
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
Canada
 
NCT01073670
ANAE-062-00
No
Dr. Joel Parlow, Head, Department of Anesthesiology & Perioperative Medicine, Queen's University and Kingston General Hospital
Queen's University
Not Provided
Principal Investigator: Joel L Parlow, MD Queen's University
Queen's University
February 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP